Spotlight On Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that primarily affects the joints and can lead to progressive joint damage and functional impairment. And because the course of RA can vary from patient to patient, timely assessment and ongoing disease management are important considerations.
Explore our Spotlight On Rheumatoid Arthritis series for expert perspectives and clinical insights on diagnosis, treatment decision-making, and strategies for long-term patient care.
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Living RheumSGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Navigating Treatment Decisions for Rheumatoid Arthritis: Key Factors to Consider
Living RheumNavigating Treatment Decisions for Rheumatoid Arthritis: Key Factors to Consider
Rheumatoid Arthritis Care: Examining the Current Landscape and Emerging Research
Living RheumRheumatoid Arthritis Care: Examining the Current Landscape and Emerging Research
How Biosimilars Can Enhance the Lives—and Savings—of Rheumatoid Arthritis Patients
Clinician's RoundtableHow Biosimilars Can Enhance the Lives—and Savings—of Rheumatoid Arthritis Patients
The Safety and Efficacy of Biosimilars in the Treatment of Rheumatoid Arthritis
Spotlight on BiosimilarsThe Safety and Efficacy of Biosimilars in the Treatment of Rheumatoid Arthritis
- advertisement
- 09/08/2026
- 08/19/2026
- 07/27/2026












